UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako initiative

Bulletin of the World Health Organization, 2003-01, Vol.81 (7), p.532-538

RIDDE, Valery

2003

Volltextzugriff (PDF)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

The Milbank quarterly, 2017-09, Vol.95 (3), p.554-601

2017

Volltextzugriff (PDF)

The effects of state‐level pharmacist regulations on generic substitution of prescription drugs

Health economics, 2018-11, Vol.27 (11), p.1717-1737

2018

Volltextzugriff (PDF)

Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists

JAMA : the journal of the American Medical Association, 2023-08, Vol.330 (7), p.650

2023

Volltextzugriff (PDF)

The Evolution of Supply and Demand in Markets for Generic Drugs

The Milbank quarterly, 2021-09, Vol.99 (3), p.828-852

2021

Volltextzugriff (PDF)

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016

Bulletin of the World Health Organization, 2018-03, Vol.96 (3), p.185-193

2018

Volltextzugriff (PDF)

Decline in economic returns from new drugs raises questions about sustaining innovations

Health Affairs, 2015-02, Vol.34 (2), p.245-252

2015

Volltextzugriff (PDF)

Global access to affordable direct oral anticoagulants

Bulletin of the World Health Organization, 2021-09, Vol.99 (9), p.653-660

2021

Volltextzugriff (PDF)

The availability, price and affordability of antidiabetic drugs in Hubei province, China

Health policy and planning, 2018-10, Vol.33 (8), p.937-947

2018

Volltextzugriff (PDF)

Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers

Health Affairs, 2015-02, Vol.34 (2), p.294-301

2015

Volltextzugriff (PDF)

Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction

Health policy (Amsterdam), 2018-03, Vol.122 (3), p.237-242

2018

Volltextzugriff (PDF)

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

Applied health economics and health policy, 2018-10, Vol.16 (5), p.653-660

2018

Volltextzugriff (PDF)

How the US Food and Drug Administration can solve the prescription drug shortage problem

American journal of public health (1971), 2013-05, Vol.103 (5), p.e10-e14

Schweitzer, Stuart O

2013

Volltextzugriff (PDF)

State generic substitution laws can lower drug outlays under Medicaid

Health Affairs, 2010-07, Vol.29 (7), p.1383-1390

2010

Volltextzugriff (PDF)

Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy

Health Affairs, 2016-05, Vol.35 (5), p.784-790

2016

Volltextzugriff (PDF)

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

Applied health economics and health policy, 2015-08, Vol.13 (Suppl 1), p.35-45

2015

Volltextzugriff (PDF)

'Government Patent Use': A Legal Approach To Reducing Drug Spending

Health Affairs, 2016-05, Vol.35 (5), p.791-797

2016

Volltextzugriff (PDF)

Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria

Health policy and planning, 2019-12, Vol.34 (Supplement_3), p.iii20-iii26

2019

Volltextzugriff (PDF)

Inflated medicine prices in Vietnam: a qualitative study

Health policy and planning, 2017-06, Vol.32 (5), p.647-656

2017

Volltextzugriff (PDF)

Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs

Health Affairs, 2016-07, Vol.35 (7), p.1237-1240

2016

Volltextzugriff (PDF)

Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community

Health policy and planning, 2017-03, Vol.32 (2), p.170-177

2017

Volltextzugriff (PDF)

Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists

Health policy (Amsterdam), 2012-01, Vol.104 (1), p.61-68

2012

Volltextzugriff (PDF)

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions

Health Affairs, 2012-10, Vol.31 (10), p.2266-2275

2012

Volltextzugriff (PDF)

A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance

Health policy (Amsterdam), 2011-02, Vol.99 (2), p.139-148

2011

Volltextzugriff (PDF)

International prices and availability of pharmaceuticals in 2005

Health Affairs, 2008-01, Vol.27 (1), p.221-233

2008

Volltextzugriff (PDF)

1 – 25 von 363

Suche als RSS-Feed

Aktive Filter

KollektionPAIS Index

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(255)

Publikationsform

Artikel
(359)
magazinearticle
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako initiative

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

The effects of state‐level pharmacist regulations on generic substitution of prescription drugs

Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists

The Evolution of Supply and Demand in Markets for Generic Drugs

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016

Decline in economic returns from new drugs raises questions about sustaining innovations

Global access to affordable direct oral anticoagulants

The availability, price and affordability of antidiabetic drugs in Hubei province, China

Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers

Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

How the US Food and Drug Administration can solve the prescription drug shortage problem

State generic substitution laws can lower drug outlays under Medicaid

Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

'Government Patent Use': A Legal Approach To Reducing Drug Spending

Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria

Inflated medicine prices in Vietnam: a qualitative study

Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs

Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community

Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions

A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance

International prices and availability of pharmaceuticals in 2005

Aktive Filter

Suchergebnisse filtern